Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenzhe Yi

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cancer Biology & Medicine|May 5, 2023
Smart drug delivery systems to overcome drug resistance in cancer immunotherapyWenzhe Yi, Dan Yan, Dangge Wang, et al.
Exploration (Beijing, China)|May 21, 2025
Synthetic Biology-Based Engineering Cells for Drug DeliveryWenzhe Yi, Shuangshuang Hu, Xindi Qian, et al.
National Science Review|March 21, 2025
Bioengineered therapeutic systems for improving antitumor immunityYing Cao, Wenlu Yan, Wenzhe Yi, et al.
Small Methods|October 28, 2022
Blocking Cholesterol Metabolism with Tumor-Penetrable Nanovesicles to Improve Photodynamic Cancer ImmunotherapyXiaochen Liu, Zitong Zhao, Xiangshi Sun, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 7, 2025
A Dendritic Cell-Nanogel Conjugate for Tumor-Draining Lymph Node-Specific PD-L1 BlockadeWenzhe Yi, Xindi Qian, Dan Yan, et al.
IEEE Transactions on Pattern Analysis and Machine Intelligence|January 14, 2026
SLeak: Multi-Target Privacy Stealing Attack against Split LearningXiaoyang Xu, Wenzhe Yi, Juan Wang, et al.
Acta Pharmaceutica Sinica. B|June 29, 2026
A lymph node-targeted cell-nanoadjuvant conjugate enhances dendritic cell-T cell crosstalk for cancer immunotherapyShuangshuang Hu, Wenzhe Yi, Zhiwen Zhao, et al.
Nature Communications|May 28, 2026
A plant vesicle-dendritic cell chimera for enhancing cancer immunotherapyWenzhe Yi, Xindi Qian, Wenlu Yan, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 23, 2025
Dendritic Cell-Based Biohybrid Immunomodulator Alleviates Intestinal Inflammatory DiseaseWenzhe Yi, Fang Sun, Xindi Qian, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 15, 2025
Dual-sensitization nanoformulation combining glutamine metabolism inhibition and Fas/FasL activation for enhanced colorectal cancer immunotherapyDan Yan, Wenzhe Yi, Ting Wu, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cancer Biology & Medicine|May 5, 2023
Smart drug delivery systems to overcome drug resistance in cancer immunotherapyWenzhe Yi, Dan Yan, Dangge Wang, et al.
Exploration (Beijing, China)|May 21, 2025
Synthetic Biology-Based Engineering Cells for Drug DeliveryWenzhe Yi, Shuangshuang Hu, Xindi Qian, et al.
National Science Review|March 21, 2025
Bioengineered therapeutic systems for improving antitumor immunityYing Cao, Wenlu Yan, Wenzhe Yi, et al.
Small Methods|October 28, 2022
Blocking Cholesterol Metabolism with Tumor-Penetrable Nanovesicles to Improve Photodynamic Cancer ImmunotherapyXiaochen Liu, Zitong Zhao, Xiangshi Sun, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 7, 2025
A Dendritic Cell-Nanogel Conjugate for Tumor-Draining Lymph Node-Specific PD-L1 BlockadeWenzhe Yi, Xindi Qian, Dan Yan, et al.
IEEE Transactions on Pattern Analysis and Machine Intelligence|January 14, 2026
SLeak: Multi-Target Privacy Stealing Attack against Split LearningXiaoyang Xu, Wenzhe Yi, Juan Wang, et al.
Acta Pharmaceutica Sinica. B|June 29, 2026
A lymph node-targeted cell-nanoadjuvant conjugate enhances dendritic cell-T cell crosstalk for cancer immunotherapyShuangshuang Hu, Wenzhe Yi, Zhiwen Zhao, et al.
Nature Communications|May 28, 2026
A plant vesicle-dendritic cell chimera for enhancing cancer immunotherapyWenzhe Yi, Xindi Qian, Wenlu Yan, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 23, 2025
Dendritic Cell-Based Biohybrid Immunomodulator Alleviates Intestinal Inflammatory DiseaseWenzhe Yi, Fang Sun, Xindi Qian, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 15, 2025
Dual-sensitization nanoformulation combining glutamine metabolism inhibition and Fas/FasL activation for enhanced colorectal cancer immunotherapyDan Yan, Wenzhe Yi, Ting Wu, et al.
Pageof 2